Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3976481 | Brachytherapy | 2016 | 8 Pages |
Abstract
Advanced tumor stage and older age seem to be independent predictors for risk of death from choroidal melanoma. The use of BT favors smaller tumors and later year of diagnosis. There is no difference in survival between those treated with EBRT or BT, and the utilization of BT is increasing.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Matthew J. Abrams, Nolan L. Gagne, Christopher S. Melhus, John E. Mignano,